Navigation Links
BioSpecifics Technologies Corp. Announces Initiation of Phase IIb Trial for Peyronie's Disease
Date:9/17/2008

ree of penile curvature (i.e. 30 degrees to 60 degrees versus > 60 degrees) and then randomized into 4 treatment groups to receive either XIAFLEX or placebo with or without modeling of the penile plaque. Modeling refers to massaging of the plaque after the second injection of a treatment series and is intended to maximize the enzymatic effect of the XIAFLEX injection in the plaque. Patients will be randomized in a 3:1 ratio of XIAFLEX to placebo and a 1:1 ratio to receive penile plaque modeling or no modeling.

About Peyronie's Disease

Peyronie's disease is characterized by the presence of a collagen plaque on the shaft of the penis, which can distort an erection and make intercourse difficult or impossible in advanced cases. The plaque is not elastic and it does not stretch during erection. In some mild cases, the plaque can resolve spontaneously without medical intervention. The most common plaque forms on the top of the penis causing the penis to arc upward. In severe cases, the penis can be bent at a 90-degree angle during erection. Significant psychological distress has been noted in patients with Peyronie's disease who are sexually active. Frequent patient complaints include increased pain, painful erections, palpable plaque, penile deformity, and erectile dysfunction. Patients with Peyronie's disease have been reported to have an increased likelihood of having Dupuytren's disease, frozen shoulder, plantar fibromatosis, knuckle pads, hypertension and diabetes. Peyronie's disease typically affects males in the range of 40-70 years. The cause of Peyronie's disease is unknown, although some investigators have proposed that it may be due to trauma or an autoimmune component. A number of researchers have suggested that the incidence of Peyronie's disease has increased due to the use of erectile dysfunction drugs.

About BioSpecifics Technologies Corp.

BioSpecifics Technologies Corp. is a biopharmaceutical company that has developed and lic
'/>"/>

SOURCE BioSpecifics Technologies Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Neurobiological Technologies Reaches Patient Enrollment Target For Interim Analysis of Viprinex(TM) Phase 3 Stroke Trials
2. New CyberKnife Technologies Demonstrate Dramatic Reduction in Treatment Times
3. MicroDose Technologies Announces Achievement of Phase I Clinical Milestone Triggering First Milestone Payment Under Collaboration with Merck & Co., Inc.
4. Wound Management Technologies, Inc. Announces Agreement for Evidence Based Study for Diabetic Venous Ulcers
5. Emisphere Technologies Announces the Launch of a Human Clinical Trial For Oral Parathyroid Hormone (PTH)
6. Duke Licenses ALPHADAS(R), Logos Technologies EDC System to Accelerate its Early Phase Clinical Trials
7. Fox Chase Cancer Center and VisEn Medical Announce Program to Advance First Clinical Trials of Novel Fluorescence Molecular Imaging Technologies
8. Disc Motion Technologies Announces First Human Implants of True TSMS(TM) Device
9. OxyBand Technologies, Inc. Hires a Leader in Medical Technology as Chief Technology Officer
10. Wound Management Technologies, Inc. Announces Evidence Based Study
11. Sahajanand Medical Technologies PAINT Trial Results Support Safety and Efficacy of the Infinnium and Supralimus Stents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... CAMBRIDGE, Mass. , Sept. 29, ... Group, Inc. (KEW), a privately held oncology services ... companies to make KEW,s state-of-the-art diagnostic services available ... KEW is a privately held oncology services company ... empowering all oncologists to access and apply genomic ...
(Date:9/29/2014)... Novogen Ltd. (ASX: NRT, NASDAQ: NVGN ) CEO ... with ABC TV that was broadcast on Saturday September 27th ... following day on Weekend Breakfast. The interview concerned the Company,s ... in Australia for the treatment of ... The interview provides certain new information and is being announced ...
(Date:9/29/2014)... , Sept. 29, 2014  Lpath, Inc. ... in bioactive lipid-targeted therapeutics, announced today the closing ... offering.  As previously disclosed, Lpath sold 3,605,042 registered ... 3,605,042 unregistered shares of common stock in a ... $3.475 per share-and-warrant-share combination.  The warrants have an ...
Breaking Medicine Technology:Cardinal Health Specialty Solutions, KEW Group Bring Power of Personalized Medicine to Community Oncologists 2Cardinal Health Specialty Solutions, KEW Group Bring Power of Personalized Medicine to Community Oncologists 3Cardinal Health Specialty Solutions, KEW Group Bring Power of Personalized Medicine to Community Oncologists 4ABC TV Interview Discusses the Potential of Trilexium(TM) to Treat Brain Cancer 2ABC TV Interview Discusses the Potential of Trilexium(TM) to Treat Brain Cancer 3Lpath, Inc. Announces Closing of $12.5 Million Registered Direct Offering 2Lpath, Inc. Announces Closing of $12.5 Million Registered Direct Offering 3
... PARK, Fla., Feb. 27, 2012 WHAT: Gearing up for its 2012 ... Fla., Transitions Optical, in conjunction with the Coconut Grove Chamber ... national travel expert Marybeth Bond, has listed the "Top 25 ... and is asking travel enthusiasts – tourists and Miami locals ...
... Calif., Feb. 27, 2012 Masimo (NASDAQ: MASI ) ... 24th Annual ROTH Conference at the Ritz Carlton Laguna Niguel in ... Pacific Time.  A live audiocast of the presentation will be available ... the audiocast will be available following the live presentation. ...
Cached Medicine Technology:Transitions Optical Kicks-Off 2012 Multi-City "Sightseeing City Tour" with Voting Contest for "Top 10 Sights to See" in Miami 2Masimo to Present at 24th Annual ROTH Conference 2Masimo to Present at 24th Annual ROTH Conference 3
(Date:9/30/2014)... Barbara Williamson shares her life story ... "An Extraordinary Life: Love, Sex and Commitment" . As ... of the highly successful and controversial Sandstone Retreat in ... the couple started what became known as the hub ... Retreat was outrageously popular, with a membership reaching 500 ...
(Date:9/30/2014)... September 30, 2014 Computer Resources ... solutions firm based in New York City, has ... Manage360° solution to transform, manage, and support the ... who is a leading provider of innovative services ... self sufficient. The contract will cover the ...
(Date:9/30/2014)... Bibliomotion is proud to announce the release ... Complex Social Age by Frank Guglielmo and ... the authors apply their leadership coaching experience to introduce Social ... actions, and behaviors that leaders must adopt in order to ... to read a review of The Social Leader in Dialogue ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 RBS Reputation Management ... service named ‘Remove Your Name’. , The service name ... reason behind giving the service this odd name, a management ... nothing odd in this name. We have named the service ... as organizations to get rid of all those posts which ...
(Date:9/30/2014)... 30, 2014 A trailblazer at heart, Dr. ... out upcoming medical breakthroughs in spine repairs. His newest ... in his patients in which he has implanted the ... components are state-of-the art and mimic normal human disc motion. ... also been proven to be an exceptional replacement device for ...
Breaking Medicine News(10 mins):Health News:The Autobiography "An Extraordinary Life: Love, Sex and Commitment" Embraces Healthy Sexual Behavior 2Health News:The Autobiography "An Extraordinary Life: Love, Sex and Commitment" Embraces Healthy Sexual Behavior 3Health News:CRA Awarded Managed Services Contract for Large NYC Nonprofit 2Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 2Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 3Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 4Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 5Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 6Health News:RBS Reputation Management Announces A New Service ‘Remove Your Name’ 2
... FL, June 30, 2010 The Florida Biomedical Research ... to three scientists from the Florida campus of The ... to Glenn Micalizio, an associate professor in the Scripps ... five years; Thomas Bannister, assistant professor of medicinal chemistry ...
... Scientists at the Stanford University School of Medicine ... finding is significant because the existence of such a ... source of debate. It may also explain why current ... human patients. "These cells lack the traditional ...
... By Randy Dotinga HealthDay Reporter , WEDNESDAY, June ... daughter avoid dementia much later on in life, a new study ... to play. Canadian researchers believe they,ve found a link between ... senior years. The study doesn,t definitively prove that exercise lowers ...
... People who care about improving the environment in life may ... Europe have developed two new and unusual methods of body ... compost method that turns bodies into soil that could ... the topic of an article in the current issue of ...
... Glinert and Jon Schommer, the associate head of the ... University of Minnesota, have examined the corporate websites dedicated ... startling lack of consistency in an industry where advertising ... (FDA). "Communicating via a website is common ...
... ... ... -- Practical solutions and protocols will once again be exchanged at Cambridge Healthtech ... Boston. The four meetings comprising the event (Optimizing Cell Culture Technology, Affinity ...
Cached Medicine News:Health News:Scripps Research scientists share $2 million in Florida state research grants 2Health News:Melanoma-initiating cell identified by Stanford scientists 2Health News:Melanoma-initiating cell identified by Stanford scientists 3Health News:Melanoma-initiating cell identified by Stanford scientists 4Health News:Exercise May Guard Girls Against Dementia in Senior Years 2Health News:Linguistics professor examines manufacturers' prescription drug websites 2Health News:Cambridge Healthtech Institute Announces its Second Annual "The Bioprocessing Summit" 2Health News:Cambridge Healthtech Institute Announces its Second Annual "The Bioprocessing Summit" 3
... The PRO6000 power supply ... Thermo's power supply product offering. ... proteomic and genomic electrophoresis. This ... to proteomic applications such as ...
... voltage power supply, the 105 is very simple ... switch control the output, which is variable in ... two-position switch toggles the bright LED display from ... is equipped with an over current detector for ...
... supply is capable of producing up to 250 ... operates in constant voltage or constant current with ... over from one mode of operation to the ... A dual function, auto ranging 24-hour up/down ...
... is designed for horizontal and vertical gel ... be accomplished. In this power supply model, ... current or constant voltage. Four sets of ... connected simultaneously. This power supply's light, compact ...
Medicine Products: